Jul 13, 2026 08:01AM
Jul 13, 2026 08:00AM
Jul 13, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
Apr 21, 2026 08:31AM
Apr 21, 2026 08:30AM Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Mar 23, 2026 08:00AM
Mar 23, 2026 08:00AM
Jan 23, 2026 08:01AM
Jan 23, 2026 08:00AM
Nov 26, 2025 08:00AM
Nov 26, 2025 08:00AM
Nov 24, 2025 10:00AM Enlivex names former Italy PM Matteo Renzi to board, raises $212M
Nov 24, 2025 10:00AM
Sep 19, 2025 09:00AM
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM
Mar 3, 2025 08:23AM
Mar 3, 2025 08:22AM
Jul 19, 2024 09:00AM Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jun 11, 2024 06:42AM
May 28, 2024 08:12AM
May 28, 2024 08:12AM
Feb 21, 2024 08:30AM
Nov 21, 2023 07:00AM
Feb 15, 2023 08:00AM
Dec 5, 2022 08:00AM Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
Nov 28, 2022 08:03AM
Nov 28, 2022 08:00AM
Sep 6, 2022 08:08AM
Sep 6, 2022 08:00AM
Aug 24, 2022 08:00AM
Aug 22, 2022 08:00AM
Jul 6, 2022 08:36AM Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Canc
Jun 6, 2022 08:00AM
May 9, 2022 09:05AM
Apr 29, 2022 08:41AM
Feb 22, 2022 08:00AM
Nov 22, 2021 08:00AM
Aug 9, 2021 08:00AM
Aug 2, 2021 08:00AM Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
Dec 21, 2020 08:09AM
Dec 21, 2020 08:00AM
Nov 17, 2020 08:18AM
Oct 1, 2020 09:30AM
Aug 25, 2020 09:30AM
Mar 18, 2020 08:04AM
Mar 18, 2020 08:00AM Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
Mar 18, 2020 08:00AM

325,450 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All